Financials
Financial year 2025
GDK PHARMACY from Grimbergen, company number BE0434953344, closed financial year 2025 with a result of € 4,366 after tax. For that financial year GDK PHARMACY recorded a gross margin of € 273,711 and equity of € 191,125. Compared with financial year 2024, the result moved from € 12,002 to € 4,366. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 191,125
▲ 6% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 4,366
▼ 64% vs 2024
Profit after tax over the fiscal year.
€ 85,224
▲ 35% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 172,525.
People and assets in 2025
3
▲ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 233,841
▲ 14% vs 2024
€ 77,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 4,953
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 294,494
▲ 4% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 28,234
▲ 3% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 291,249 | € 262,344 | € 256,120 | € 273,711 | ▲ 7% |
| Profit after taxes | € -18,515 | € -491 | € 12,002 | € 4,366 | ▼ 64% |
| Equity | € 169,051 | € 168,560 | € 180,561 | € 191,125 | ▲ 6% |
| Total debts | € 395,454 | € 553,028 | € 415,416 | € 477,566 | ▲ 15% |
| Cash | € 11,241 | € 40,527 | € 63,038 | € 85,224 | ▲ 35% |
| Retained profit | € 156,648 | € 156,157 | € 168,159 | € 172,525 | ▲ 3% |
| Balance sheet total | € 564,505 | € 721,588 | € 595,977 | € 668,691 | ▲ 12% |
| Employees (FTE) | 4.4 | 3.3 | 2.8 | 3 | ▲ 0.2 |
Key figures of GDK PHARMACY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to GDK PHARMACY?
What happened at GDK PHARMACY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 4,366 (▼ 64% vs 2024). Source: NBB ↗
- New establishment in Jette. KBO
- Start of the company according to the CBE. KBO
In short
From € 18,515 loss in 2022 to € 4,366 profit in 2025.
Paid € 20,255 in corporate taxes since 2022.
Best year ever: 2024, with € 12,002 profit.
On average € 91,200 of value added per employee in 2025.
Management
The stake of GDK FARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
GDK PHARMACYBehind GDK PHARMACY is NV GDK FARMA. The shares are held by GDK FARMA (99.9%).
Directors
According to the 2025 annual accounts
Shareholders
99.9%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Romeinsesteenweg 450-452
1853 Grimbergen
Laarbeeklaan 101
1090 Jette
Active since 5 September 1988
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0434.953.344
- VAT number
- BE 0434.953.344
- Registered office
- Romeinsesteenweg 450-452, 1853 Grimbergen
- Names & denominations
- GDK PHARMACY
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 August 1988
- Peppol
- Active · Active since 26 Nov 2024
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten